Fredun Pharmaceuticals Limited (BOM:539730)
India
· Delayed Price · Currency is INR 710.05
+8.55 (1.22%)
At close: May 5, 2025
Fredun Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | 156.23 | 108.07 | 63.35 | 20.15 | 19.02 | Upgrade
|
| Depreciation & Amortization | 37.42 | 27.65 | 21.33 | 19.82 | 18.66 | Upgrade
|
| Other Amortization | 0.54 | 0.44 | 0.24 | 0.22 | 0.13 | Upgrade
|
| Other Operating Activities | 187.99 | 155.43 | 79 | 66.47 | 45.66 | Upgrade
|
| Change in Accounts Receivable | -302.89 | 557.13 | -491.98 | -21.01 | -150.12 | Upgrade
|
| Change in Inventory | -248.74 | -1,037 | 211.14 | -171.13 | -96.82 | Upgrade
|
| Change in Accounts Payable | 36.04 | 107.26 | -113.44 | 137.37 | 104.84 | Upgrade
|
| Change in Income Taxes | 12.45 | -27.91 | -5.45 | -21.99 | 4.34 | Upgrade
|
| Change in Other Net Operating Assets | 116.57 | -35.53 | 212 | -28.2 | -52.15 | Upgrade
|
| Operating Cash Flow | -4.39 | -144.09 | -23.8 | 1.7 | -106.44 | Upgrade
|
| Capital Expenditures | -76.39 | -94.95 | -42.86 | -13.88 | -14.93 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.9 | 1.43 | - | - | Upgrade
|
| Investing Cash Flow | -76.39 | -94.05 | -41.43 | -13.88 | -14.93 | Upgrade
|
| Short-Term Debt Issued | 216.05 | 271.78 | 1.97 | - | 173.2 | Upgrade
|
| Long-Term Debt Issued | - | 68.89 | 129.29 | 176.15 | 8.57 | Upgrade
|
| Total Debt Issued | 216.05 | 340.67 | 131.25 | 176.15 | 181.77 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -128.71 | - | Upgrade
|
| Long-Term Debt Repaid | -26.42 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -26.42 | - | - | -128.71 | - | Upgrade
|
| Net Debt Issued (Repaid) | 189.63 | 340.67 | 131.25 | 47.44 | 181.77 | Upgrade
|
| Other Financing Activities | -129.7 | -88.9 | -56.58 | -54.57 | -44.48 | Upgrade
|
| Financing Cash Flow | 59.93 | 251.77 | 74.67 | -7.13 | 137.29 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | 0 | - | Upgrade
|
| Net Cash Flow | -20.85 | 13.63 | 9.44 | -19.31 | 15.92 | Upgrade
|
| Free Cash Flow | -80.78 | -239.03 | -66.66 | -12.18 | -121.37 | Upgrade
|
| Free Cash Flow Margin | -2.32% | -8.70% | -2.97% | -0.91% | -10.77% | Upgrade
|
| Free Cash Flow Per Share | -17.40 | -53.38 | -16.05 | -3.05 | -30.42 | Upgrade
|
| Cash Interest Paid | 136.5 | 92.82 | 46.69 | 41.62 | 44.14 | Upgrade
|
| Levered Free Cash Flow | -269.38 | -445.24 | -337.49 | -79.01 | -137.06 | Upgrade
|
| Unlevered Free Cash Flow | -191.14 | -397.98 | -310.05 | -55.02 | -111.54 | Upgrade
|
| Change in Net Working Capital | 367.08 | 488.41 | 362.13 | 106.25 | 156.62 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.